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ABSTRACT
Despite longstanding evidence that hypoglycaemic neuronal
injury is mediated by glutamate excitotoxicity, the cellular
and molecular mechanisms involved remain incompletely
defined. Here, we demonstrate that the excitotoxic neuronal
death that follows GD (glucose deprivation) is initiated by
glutamate extruded from astrocytes via system xc
2 –a n
amino acid transporter that imports L-cystine and exports L-
glutamate. Specifically, we find that depriving mixed cortical
cell cultures of glucose for up to 8 h injures neurons, but
not astrocytes. Neuronal death is prevented by ionotropic
glutamate receptor antagonism and is partially sensitive to
tetanus toxin. Removal of amino acids during the de-
privation period prevents – whereas addition of L-cystine
restores – GD-induced neuronal death, implicating the
cystine/glutamate antiporter, system xc
2. Indeed, drugs
known to inhibit system xc
2 ameliorate GD-induced neu-
ronal death. Further, a dramatic reduction in neuronal death
is observed in chimaeric cultures consisting of neurons de-
rived from WT (wild-type) mice plated on top of astrocytes
derived from sut mice, which harbour a naturally occurring
null mutation in the gene (Slc7a11) that encodes the
substrate-specific light chain of system xc
2 (xCT). Finally,
enhancement of astrocytic system xc
2 expression and
function via IL-1b (interleukin-1b) exposure potentiates
hypoglycaemic neuronal death, the process of which is
prevented by removal of L-cystine and/or addition of system
xc
2 inhibitors. Thus, under the conditions of GD, our studies
demonstrate that astrocytes, via system xc
2, have a direct,
non-cell autonomous effect on cortical neuron survival.
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INTRODUCTION
Hypoglycaemia is a medical emergency that arises as a serious
complication of insulin therapy in diabetic patients. It is also
prevalent in neonates, in patients with insulin-producing
tumours, and can occur as a consequence of brain ischaemia.
Severe hypoglycaemia, defined as less than 2 mM blood
glucose, essentially renders the brain aglycaemic, leading to
cognitive impairments and frank neuronal injury (Ryan et al.,
1990; Langan et al., 1991; Suh et al., 2007a; Xu et al., 2011a).
Evidence indicates that hypoglycaemic/aglycaemic neuronal
cell death is mediated by glutamate excitotoxicity (Wieloch,
1985; Monyer et al., 1989). Following activation of glutamate
receptors, a cascade of biochemical events is initiated that
ultimately leads to neuronal cell death via processes de-
pendent on reactive oxygen species, neuronal zinc release,
activation of poly(ADP-ribose) polymerase-1, and alterations
in mitochondrial function. Inhibition of these downstream
targets of glutamate receptor activation show some success
in reducing hypoglycemic brain injury (for review, see Suh
et al., 2007b). However, the cellular source and molecular
mechanisms by which glutamate is released remain incom-
pletely defined.
The contribution of both synaptic and non-synaptic
sources of glutamate to excitotoxic neuronal injury under
conditions of energy deprivation has been demonstrated. Yet,
until recently, most therapeutic protective strategies have
focused solely on the neuron, despite numerous studies that
highlight the importance of the astrocyte to neuronal survival
(Chen and Swanson, 2003). While its role in neuroprotection is
best appreciated, several studies now demonstrate the
contribution of the astrocyte to neuronal cell death (for
review,see Barbeito et al., 2004; Lobsiger and Cleveland, 2007).
With respect to this, recent work from our laboratory
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2 (cystine/glutamate
antiporter) activity contributes to hypoxic neuronal death
via a glutamate-mediated mechanism (Fogal et al., 2007;
Jackman et al., 2010b). System xc
2 is a heteromeric amino
acid transporter consisting of two subunits: xCT – the light
chain conferring substrate specificity – and a heavy chain
thought to target the transporter to the plasma mem-
brane (Sato et al., 1999; Bassi et al., 2001). The import of
cystine via system xc
2 is directly coupled to glutamate
export, which occurs in a Na
+-independent manner (Bannai
and Kitamura, 1980). Enhanced system xc
2 activity has
been previously reported to contribute to excitotoxic
neuronal death in numerous other experimental paradigms
as well (Piani and Fontana, 1994; Ye et al., 1999; Barger
and Basile, 2001; Qin et al., 2006; Savaskan et al., 2008;
Sontheimer, 2008; Massie et al., 2011). Although system
xc
2 is functionally active in neurons, astrocytes and
microglia (Burdo et al., 2006; Dun et al., 2006; Domercq
et al., 2007; La Bella et al., 2007; Jackman et al., 2010b),
herein, we describe astrocytic system xc
2 as the source of
glutamate required for the initiation of non-cell autonom-
ous neuronal death following GD (glucose deprivation) in
vitro.
Part of the work has been published in abstract form
(Jackman et al., 2010a).
MATERIALS AND METHODS
Cell culture
All media including media stock, glial plating medium,
neuronal plating medium, mixed culture plating medium and
maintenancemediumhavebeenfullydescribed(Jackmanetal.,
2010b). The glucose-free BSS0 (balanced salt solution)
contains: 116 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2,1m M
NaH2PO4, 26.2 mM NaHCO3, 1.8 mM CaCl2, 0.01 mM glycine,
2m ML-glutamine and 16MEM amino acids. For most ex-
periments, BSS0 contains purchased 16MEM amino acids
(Invitrogen); however, amino acids were reconstituted indi-
vidually for the removal and addition experiments. With the
exception of the concentration-response experiment, BSS0
contained 100 mM cystine, the standard concentration found
in cell culture medium.
Primary astrocyte cultures were derived from cerebral
cortices of day 1–3 postnatal CD1 mouse pups (Charles River)
as described (Trackey et al., 2001). This plating procedure
routinely produces monolayers of protoplasmic-like astro-
cytes, which following confluence are treated with 8 mM
AraC (b-D-cytosine arabinofuranoside; Sigma Chemical Co.)
once, for 5–6 days, to prevent microglia cell growth. WT
(wild-type) and sut (xCT-deficient) astrocytes were cultured
from cortices of single pups derived from sut/+ breeding pairs
(JAX; Stock no. 001310). 2-Mercaptoethanol (55 mM) was
added to the glial plating medium of sut cultures to support
growth and to WT cultures for control purposes (Shih et al.,
2006; Jackman et al., 2010b). The rest of the brain was used
for genotyping: WT primers (230 bp product) 59-GAAG-
TGCTCCGTGAAGAAGG-39 (forward), 59-ATCTCAATCCTGG-
GCAGATG-39 (reverse); sut primers (<2280 bp product) 59-
CCACTGTTGTAGGTCAGCTTAGG-39 (forward), 59-CAGG-
ACCTGTGAATATGATAGGG-39 (reverse). Purified astrocyte cul-
tures were obtained by incubating astrocyte monolayers with
75 mM leucine methyl ester to remove any residual microglia
as previously described (Hamby et al., 2006; Jackman et al.,
2010b). At the time of experimentation, cultures were #35
days in vitro.
Primary neuronal cultures were derived from dissociated
cortical cells of embryonic day 15 CD1 (Charles River) mouse
fetuses (Brewer et al., 1993). Two days after plating in
neuronal plating medium, cultures were treated with 1 mM
AraC once for 2 days to prevent glial cell growth. The medium
was partially replenished (K volume exchange) twice weekly.
Experiments were performed on purified neuronal cultures
after 7–10 days in vitro.
Mixed cortical cell cultures containing an approximate
50:50 neuron to astrocyte ratio were prepared by culturing
dissociated cells from embryonic day 15 mouse fetuses on to
a confluent layer of microglia-depleted astrocytes in mixed
culture plating media as described in detail (Trackey et al.,
2001; Jackman et al., 2010b). Experiments were performed on
mixed cortical cultures after 13–14 days in vitro.
GD
Mixed cortical cell cultures were washed thoroughly (86750
ml) into BSS0. Glucose (final concentration510 mM) was
immediately added to parallel cultures to serve as controls and
at times added back to experimental conditions as indicated in
each Figure legend. It should be noted that during the course
oftheexperiments,wefoundthatdeath measuredat8 hpost-
aglycaemia was essentially the same as that measure 20–24 h
laterfollowing a glucose ‘rescue’, indicating thatcelldeath was
complete at 8 h and the glucose add-back was unnecessary
and non-helpful. Inhibitors – with the exception of an
overnight incubation with tetanus toxin – were given at the
initiation of GD.
Measurement of cell death
Cell death was quantitatively determined by spectrophoto-
metric measurement of LDH (lactate dehydrogenase) as
described previously (Uliasz and Hewett, 2000). Neuronal cell
death is expressed as a percentage of total neuronal LDH
activity (defined as 100%) determined by exposing parallel
cultures to 250 mM NMDA (N-methyl-D-aspartate) (20–24 h).
Since cultured cortical astrocytes neither express NMDA
receptors (Backus et al., 1989; Chan et al., 1990; Janssens and
Lesage, 2001; B. Fogal and S.J. Hewett, unpublished data) nor
are injured by GD up to 8 h (Figure 1, inset), changes in LDH
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neuronal death. In most but not all cases, ‘basal’ LDH released
from control cultures (attrition due to extensive washes) was
subtracted from values obtained in experimental conditions
to yield the signal specific to hypoglycaemic death. To quan-
tify astrocyte death, astrocyte release of LDH under control
and experimental conditions was expressed as a percentage
of total astrocyte LDH activity (defined as 100%), determined
by exposing parallel cultures to 5 mM Calphostin C for 20–
24 h (Ikemoto et al., 1995).
IL-1b (interleukin-1b) treatment
To selectively enhance astrocytic system xc
2 expression/
activity (Jackman et al., 2010b), cultures were treated with
0.01–1 ng/ml recombinant murine IL-1b (R&D Systems) in
an incubation buffer of media stock supplemented with
0.1% fatty-acid-free BSA (Sigma). The vehicle used in all
other conditions was media stock supplemented with
0.1% fatty-acid-free BSA.
qPCR (quantitative PCR)
qPCR was performed using mouse-specific primer pairs
[Taqman Gene Expression Assays, Applied Biosystems: xCT
(Mm00442530_m1)] per manufacturer’s instructions using
the comparative cycle threshold method (DDCT) with b-actin
as the housekeeping control as described (Jackman et al.,
2010b). Importantly, b-actin CT values were unaffected by IL-
1b treatment. Amplification efficiency was .94%.
Statistical analysis
Statistical analyses were performed using GraphPad Prism
Software (Version 4.03) as described in each Figure legend.
Because normalized data are, by nature, not normally
distributed, percentage data were first transformed via arcsin
square root (Steel and Torrie, 1980). Likewise, for qPCR,
statistics were performed on the logarithmic retransforma-
tion (i.e. geometric means) of 2
2DDCT values. In all
experiments, data are expressed as the means¡S.E.M.
Significance was assessed at P,0.05.
RESULTS
As reported previously, selective neuronal degeneration
occurred in a time-dependent manner in mixed cortical cell
culture following GD (Figure 1), whereas purified astrocytes
(Figure 1, inset) and astrocytes in mixed cultures (Figures 4b
and 4d) were resistant for up to 8 h, the longest time-point
assessed (Monyer and Choi, 1988; Monyer et al., 1989;
Goldberg and Choi, 1993). Also in agreement with previous
studies (Monyer and Choi, 1988; Monyer et al., 1989), neuronal
injury was prevented by ionotropic glutamate receptor
antagonism (Figure 2). The small amount of death that is
found in control cultures (1–10%) reflects LDH release that
results from the extensive washing (i.e. wash damage) that is
used to render the cultures aglycaemic.
Figure 1 GD injures neurons, but not astrocytes in vitro
Mixed cortical cultures or purified astrocytes (inset) were washed into an
incubated medium containing (hatched bars) or lacking (black bars) glucose.
The percentage of total cell death was determined at the times indicated.
Between group differences (*) were determined by one-way (astrocytes) or
two-way ANOVA (mixed cultures) followed by Bonferroni’s post-hoc test
(n511–12 cultures from four independent experiments).
Figure 2 Hypoglycaemic neuronal cell death is attenuated by glutamate
receptor antagonism
Mixed cortical cultures were washed into a BSS0 containing vehicle, MK-801
(10 mM) or MK-801 plus CNQX (6-cyano-7-nitroquinoxaline-2,3-dione;
30 mM) for 8 h (GD). Neuronal cell death was determined 20–24 h later.
(*) Indicates values significantly different from control conditions
(510.56¡3.02%) determined 24 h following wash of cells into BSS0
followed by immediate addition of glucose. (#) Represents a significant
diminution of GD-induced cell death as determined by one-way ANOVA
followed by Student–Newman–Keul’s post-hoc test (n511 cultures from
three experiments).
Astrocytes initiate aglycaemic injury
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25Overnight incubation of cultures with tetanus toxin prior
to GD slightly, but significantly, attenuated neuronal damage
in our system (Figure 3). More strikingly, addition of dual
system xc
2/mGluR1a antagonists [4-CPG (4-carboxyphenyl-
glycine) or LY367385; 50 mM] (Gochenauer and Robinson,
2001) dramatically attenuated neuronal cell death resulting
from GD (Figure 4). A role for mGluR1 is unlikely, given that
the selective mGluR1 antagonist, YM298198 (10 mM), did not
protect in this injury model. Importantly, all three inhibitors
reduced dihydroxyphenylglycine (i.e. mGluR1)-mediated
enhancement of hypoxic neuronal cell death at the
concentrations utilized here (Fogal et al., 2007), demonstrat-
ing their effectiveness. These latter data suggest a role for
system xc
2.
In support of this contention, we find that hypoglycaemic
neuronal cell death occurred only in buffer containing amino
acids, with an absolute requirement for L-cystine (Figure 5).
Indeed, neuronal cell death was completely prevented when L-
cystine alone was lacking during the deprivation period
(Figure 5A), whereas addition of only L-cystine allowed
hypoglycaemic neuronal cell death to ensue (Figure 5B).
Although the concentration of L-cystine routinely found in
tissue culture medium (100 mM) resulted in maximal cell death,
significant injury was observed at 25 mM (Figure 5C), which is
nearly identical with the calculated Km for
14C-L-cystine
uptake into our cultures (Fogal et al., 2007). Removal and/or
addition of L-methionine had no effect (Figures 5A and 5B),
attesting to the specificity of the response for L-cystine.
Methionine was chosen because, like cystine, it can be
converted in the brain into cysteine via transulfuration
(Vitvitsky et al., 2006).
In our cultures, astrocytes and neurons express xCT and
functional system xc
2 activity (Jackman et al., 2010b) in an
apparent 2:1 ratio (Figure 6). Thus, to determine whether
cell-autonomous or non-cell autonomous alterations in
system xc
2 activity underlie the initiation and/or progression
of neuronal cell death, we prepared chimaeric cultures
consisting of WT neurons plated on top of astrocytes derived
from mice harbouring a null mutation in Slc7a11 (sut gene),
which encodes xCT, the light subunit of system xc
2 (Chintala
et al., 2005), and then deprived them of glucose. In
comparison with cultures containing both WT neurons and
astrocytes, neuronal cell death following GD was substan-
tially reduced in chimaeric cultures (Figure 7). Notably, WT
neurons plated on sut astrocytes were equally sensitive to
injury invoked by NMDA exposure (Figure 7, inset; 100%
neuronal death). Additionally, the comparable LDH values
measured following NMDA exposure demonstrate that
neurons plated on WT or sut astrocytes had similar growth
properties/cell densities. Hence, the differences in hypogly-
caemic cell death observed when neurons were plated on sut
astrocytes can neither be explained by alterations in cell
density nor by a global reduction in neuronal susceptibility
to an excitotoxic insult. Finally, selective enhancement of
xCT mRNA expression (Figure 8A) and xCT protein expression
in astrocytes and not neurons (Jackman et al., 2010b)
following IL-1b treatment resulted in a potentiation of
hypoglycaemic neuronal cell death (Figure 8B). This IL-1b-
potentiated hypoglycaemic neuronal cell death was blocked
by the use of the system xc
2 antagonists, 4-CPG and
LY367385, and/or by removal of the system xc
2 substrate,
Figure 3 Inhibition of synaptic release of glutamate partially attenuates
GD-induced neuronal cell death
Mixed cultures were incubated overnight with tetanus toxin (TeNT; 0.3–3 mg/
ml) or its vehicle then washed into a BSS0 (GD). Eight hour later, glucose
(10 mM) was added and the cultures were placed back into the incubator,
after which neuronal cell death was assessed 20–24 h later. NB: Values for
GD indicate that all the neurons (100%) plus some of the astrocytes (7–8%)
were killed. (*) Indicates values significantly different from control conditions
(52.06¡0.8%) determined by washing cells into BSS0 followed by
immediate addition of glucose, whereas (#) represents a significant
diminution from GD-induced neuronal cell death as determined by one-
way ANOVA followed by Student–Newman–Keul’s post-hoc test (n53).
Figure 4 System xc
2 antagonism prevents neuronal cell death
Mixed cortical cultures were washed into BSS0 in the presence or absence
of the dual system xc
2/mGluR1 antagonists 4-CPG (50 mM) and LY367385
(50 mM), or the selective mGluR1 inhibitor, YM298198 (10 mM). Eight hours
later, supernatant was collected for measurement of neuronal cell death. (*)
Indicates values that are significantly different from control conditions
(57.98¡0.89%) determined by washing cells into BSS0 followed by
immediate addition of glucose, while (#) represents a significant diminution
from GD-induced neuronal death as assessed by one-way ANOVA followed
by Student–Newman–Keul’s post-hoc test (n511–12 cultures from three
independent experiments). Right: Representative phase micrographs of
mixed cortical cultures: (a) control; (b) 8 h GD; (c) GD+4-CPG (50 mM);
(d) GD+YM298198 (10 mM).
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with the obligate requirement of astrocytic system xc
2 in
hypoglycaemia-induced excitotoxic neuronal cell death in this
paradigm.
DISCUSSION
When blood glucose concentrations fall below 2 mM
(normal54–7 mM), brain glucose levels approach zero (Choi
et al., 2001), precipitating neuronal injury (Ryan et al., 1990;
Langan et al., 1991; Suh et al., 2007b; Xu et al., 2011b).
Neurons, especially those residing in the hippocampus and
cortex, are highly sensitive to GD (Auer et al., 1984; Monyer
and Choi, 1988; Monyer et al., 1989; Goldberg and Choi,
1993), whereas astrocytes have been demonstrated to be
more resistant (Monyer and Choi, 1988; Monyer et al., 1989;
Goldberg and Choi, 1993; Lyons and Kettenmann, 1998)
(Figure 1). This is in accordance with the findings that rapid
Figure 5 Hypoglycaemic neuronal death is dependent on L-cystine
(A) Mixed cultures were deprived of glucose (4 h) in a medium containing
(GD) or lacking (2AA) MEM amino acids, L-cystine (2CYSS) alone or L-
methionine (2MET) alone. (*) Indicates values significantly different from
control (50.55¡0.28%); (#) represents a significant diminution from GD-
induced neuronal death as determined by one-way ANOVA followed by
Student–Newman–Keul’s post-hoc test (n524 cultures from six independent
experiments). (B) Cultures were deprived of glucose (4 h) in a medium
containing (GD) or lacking (2AA) MEM amino acids save for supplementation
with 100 mM L-cystine (+CYSS) or 100 mM L-methionine (+MET). (*) Indicates
values different from control (52.87¡0.38% death), while (#) represents a
significant diminution from GD-induced neuronal death as determined by
one-way ANOVA followed by Student–Newman–Keul’s post-hoc test (n54).
(C) Cultures were deprived of glucose for 8 h in a medium containing MEM
amino acids and various concentrations of cystine (0–100 mM), after which
neuronal death was assessed. (*) Indicates values significantly different from
control conditions (57.11¡1.27%) as determined by one-way ANOVA
followed by Dunnett’s post-hoc test (n54).
Figure 6 System xc
2 expression and activity is higher in astrocytes than in
neurons
(A) Total RNA was isolated from unstimulated pure astrocytes and pure
neurons (n53 cultures each from three independent experiments), reverse
transcribed and relative basal expression of xCT mRNA was assessed via
qPCR. Data are expressed as means¡S.E.M. fold change in mRNA compared
with pure astrocyte cultures (set at 1). No statistical difference was noted.
(B) Pure astrocytes (n512 cultures from three independent experiments) and
pure neurons (n58 cultures from two independent experiments) were
washed and incubated with an uptake buffer containing
14C-L-cystine (3 mM)
for 30 min. Data are expressed as means¡S.E.M.
14C-L-cystine uptake in
pmol/30 min/mg protein. An asterisk (*) denotes values different from
neurons as assessed by a Student’s t test. Significance was set at P,0.05.
Astrocytes initiate aglycaemic injury
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27ATP depletion occurs exclusively in neurons following GD in
vitro (Choi et al., 2008) and that astrocytes contain glycogen
stores (Cataldo and Broadwell, 1986; Swanson et al., 1990)
that can be metabolized to meet their own metabolic needs
(Swanson et al., 1990; Erecinska and Silver, 1994; Dienel and
Cruz, 2006; Walls et al., 2009). Additionally, the ability to
convert glutamate to pyruvate provides another possible
mechanism whereby the tricarboxylic acid cycle in astrocytes
can be maintained when levels of glucose are low (Bakken
et al., 1998).
Despite this, neuronal cell death does not appear to be a
direct result of energy failure. In fact, several studies demon-
strate that hypoglycaemic neuronal injury occurs secondary to
glutamate excitotoxicity, as insulin-induced hypoglycaemia
results in glutamate accumulation in the rat hippocampus and
striatum (Sandberg et al., 1986; Silverstein et al., 1990) and in
the cerebrum of the pig (Ichord et al., 1999) as measured by
microdialysis.Moreover,ionotropicglutamatereceptor antago-
nists protect against injury both in vivo and in vitro (Wieloch,
1985; Monyer and Choi, 1988; Monyer et al., 1989; Nellgard
and Wieloch, 1992; Tasker et al., 1992; Ichord et al., 2001)
(Figure 2). Nevertheless, questions concerning the cellular
source and molecular mechanisms surrounding glutamate re-
lease following hypoglycaemia remain.
In vivo deafferentation studies suggest a neuronal contri-
bution to hypoglycaemic neuronal cell death (Wieloch et al.,
1985). Consistent with the work of Choi and co-workers
(Monyer et al., 1992), we found partial but significant
protection with tetanus toxin (3 mg/ml), suggesting that
exocytotic release of glutamate may contribute slightly to
hypoglycaemic neuronal cell death. However, it should be
noted that 300 ng/ml – a concentration that we have
previously shown to cleave neuronal synaptobrevin and block
depolarization-induced glutamate release as well as high K
+-
induced neuronal cell death (Taylor and Hewett, 2002; Fogal
etal.,2005),slightlybutnon-significantlyattenuated neuronal
death in our hands (Figure 3). Certainly, the effect of tetanus
toxin at this concentration was not as robust as that observed
following pharmacological inhibition of system xc
2 (Figure 4)
or via removal of its substrate, L-cystine (Figure 5). Although
selectiveinhibitorsforsystemxc
2arenotavailableatthistime,
two CPG derivatives, best known for their ability to inhibit
mGluR1 (i.e. 4-CPG and LY367385), were used to inhibit this
transporter (Gochenauer and Robinson, 2001). A role for
mGluR1 is unlikely, because the selective mGluR1 antagonist,
YM298198, did not protect in this injury model. A role for
mGluR5 is also unlikely as LY367385 (unlike 4-CPG) has no
effect on mGluR5 (Watkins and Collingridge, 1994; Brabet
et al., 1995; Kingston et al., 2002; Patel et al., 2004). These
pharmacological studies and data obtained from sut-derived
chimaeric cultures (Figure 7) implicate astrocytic system xc
2,
which translocates glutamate into the extracellular space.
While elimination of astrocytic system xc
2 is sufficient to
prevent GD-induced neuronal death, we also found that
enhancement of astrocytic system xc
2 could potentiate injury
(Figure 8). Although IL-1b was utilized as a tool in this study,
and is capable of altering the expression of other cellular
proteins besides astrocyte xCT, our data demonstrating that its
injury potentiating effects are dependent on cystine and
blocked by system xc
2 pharmacological antagonism (Figure 8)
argue for theprimacy of system xc
2over other potential targets.
Our previous data, showing no effect of IL-1b on neuronal xCT
expressionorfunction,pointstothecentralroleoftheastrocyte
(Jackman et al., 2010b). Additionally, it is notable that diabetics
have increased IL-1b serum levels compared with healthy
individuals (Dogan et al., 2006). Given the increasing evidence of
cross-talk between the peripheral immune and CNSs (central
nervous systems), it is intriguing to speculate that there may be
some physiological relevance (Figure 8).
An important caveat with respect to this study is the lack of
information regarding the extracellular concentrations
of cystine that exist either basally or under pathological
conditions in the cerebral cortex. Herein, we demonstrate
neuronal cell death with cystine concentrations at or above 25
mM (Figure 5C). This is in good agreement with the effective
Km of system xc
2, which has been estimated in numerous in
vitro preparations– includingourown (<30mM) – to be in the
range of 10–100 mM (Bannai and Kitamura, 1982; Hosoya
et al., 2002; McBean, 2002; Fogal et al., 2007; Bridges, 2012).
However, microdialysis measurements made in the nucleus
accumbens demonstrate that the extracellular L-cystine
concentration may be rather low (0.1–0.2 mM) (Baker et al.,
2003), which some investigators interpret to mean that system
Figure 7 Hypoglycaemic neuronal death is dependent on astrocyte system
xc
2
Chimaeric cultures were obtained by plating WT neurons on astrocytes
derived from sut mice (hatched white bars). These and control cultures (WT
neurons on WT astrocytes; black bars) were washed into BSS0, glucose added
(final510 mM) immediately to control cultures (0 h) or 8 h later to
previously glucose-deprived cells (8 h), and neuronal cell death determined
20–24 h later. (*) Indicates a significant within-group difference, while (#)
indicates a significant between-group difference as determined by two-way
ANOVA followed by Bonferroni’s post-hoc test (n515–18 cultures from three
independent experiments). Inset: LDH absorbance values for chimaeric and
control cultures treated with 250 mM NMDA for 20–24 h.
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2 has no physiological role in vivo. Yet, numerous studies
demonstrate that system xc
2 is an important contributor to
the ambient extracellular glutamate levels that bathe the CNS
in vivo (Jabaudon et al., 1999; Warr et al., 1999; Baker et al.,
2002a, 2002b; Melendez et al., 2005; Augustin et al., 2007;
Featherstone and Shippy, 2008; Massie et al., 2011; De Bundel
et al., 2011) with maximal transporter activity estimated to
theoretically increase extracellular glutamate by 0.6 mM/s
(Cavelier et al., 2005). Additionally, direct comparison of
measurement made in accumbens should not be extrapolated
to cortex as differences in astrocyte biochemistry, physiology
and function may be region specific (for reviews, see Hewett,
2009; Matyash and Kettenmann, 2010; Zhang and Barres,
2010). Further, insertion of a microdialysis probe can produce
substantial tissue and vasculardamagealteringtheaccuracyof
the measurements obtained (Westergren et al., 1995; Clapp-
Lilly et al., 1999); and substantial technical difficulties have
been reported when measuring cystine and cysteine concen-
trations (Bannai, 1984; Massie et al., 2011; De Bundel et al.,
2011). Finally, it is important to note that plasma concentra-
tions of cystine range from 5 to 60 mM (Brigham et al., 1960;
Crawhall et al., 1968; Bannai, 1984; Eck et al., 1989; Wang and
Cynader, 2000; Jones et al., 2002), which as stated above, is in
line with the reported Km value for cystine transport viasystem
xc
2. Due to the close apposition of astrocytes and blood
vessels, cystine need only diffuse a small distance; thus it
would not be surprising to find small concentrations in the
extracellular space. This is reminiscent of the way excitatory
amino acid transporters maintain low extracellular levels
of glutamate with Km values ranging from 1 to 100 mM
(Danbolt, 2001). Further, despite the low levels of extracellular
cystine measured in the accumbens, Baker and
co-workers convincingly demonstrate that adaptations in
system xc
2 underlie cocaine relapse in rat (Baker et al., 2003;
Kau et al., 2008) and contribute to the psychotomimetic
effects of phencyclidine (Baker et al., 2008).
Additionally, the activity of system xc
2 has been linked to
excitotoxic neuronal cell death in a number of experimental
paradigms in vivo. For instance, the export of glutamate via
system xc
2 produces an excitotoxic necrosis that aids in
glioma tumour growth and invasion (Savaskan et al., 2008;
Sontheimer, 2008). Dopaminergic neuronal cell death induced
by 6-hydroxydopamine is reduced in xCT knockout mice
(Massie et al., 2011). While the contribution of system xc
2 has
not been definitively characterized in cerebral ischaemic
injury, systemic administration of CPG derivatives has been
demonstrated to decrease the infarct volume after MCAO
(middle cerebral artery occlusion) in rat (Moroni et al., 2002),
a protective effect originally ascribed to inhibition of
mGluR1. Yet, compared with their WT controls, neuronal
injury following MCAO is not reduced in mGluR1-deficient
mice (Ferraguti et al., 1997). Thus, inhibition of system xc
2
might underlie the protection of so-called mGluR1 antago-
nists in the aforementioned studies given their known ability
to inhibit the system xc
2 transporter (Gochenauer and
Robinson, 2001).
T h ef a c tt h a ts y s t e mx c
2 contributes to injury might seem
paradoxical given its importance in the biosynthesis of the
antioxidant molecule GSH (Watanabe and Bannai, 1987; Bannai
et al., 1989; Miura et al., 1992; Sato et al., 1995; Bridges et al.,
2001; Dun et al., 2006; Lewerenz et al., 2009). Ironically, while
this pathway allows the CNS to rapidly up-regulate GSH in
Figure 8 Enhanced astrocyte system xc
2 activity potentiates hypogly-
caemic neuronal death
(A) Purified astrocytes (n53 from three independent experiments) were
incubated with IL-1b or vehicle (media stock supplemented with 0.1% fatty-
acid-free BSA) for 6 h, after which xCT mRNA expression was assessed.
(*) Denotes values different from 0 h as determined by one-way ANOVA
followed by Dunnett’s post-hoc test. (B) Mixed cultures were incubated with
IL-1b for 20–24 h then washed into BSS0. Glucose was added after 3.5 h and
neuronal cell death determined 20–24 h later. (*) Indicates values different
from control (0 ng/ml IL-1b) as determined by one-way ANOVA followed by
Dunnett’s post-hoc test (n516 cultures from four independent experiments).
(C) Mixed cultures were incubated with IL-1b (GD+IL-1b) or vehicle (GD) for
20–24 h, then washed into BSS0 containing 4-CPG (50 mM) or LY367385
(50 mM) or one lacking cystine (2CYSS) for 4 h. (*) Indicates values different
from GD. (#) Represents a significant diminution from the IL-1b-mediated
potentiation of GD-induced neuronal death as determined by one-way
ANOVA followed by Student–Newman–Keul’s post-hoc test (n56–16
cultures from four independent experiments).
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29response to an oxidative challenge, it also holds the poten-
tial to exacerbate CNS pathology via extrusion of glutamate
into the extracellular space. As such, it is becoming in-
creasingly clear that the consequences of system xc
2
activity are context-dependent whereby import of cystine is
physiologically beneficial (Tanaka et al., 1999; Shih et al.,
2003; Jakel et al., 2007) and/or can contribute to patho-
physiology under certain conditions (Piani and Fontana,
1994; Ye et al., 1999; Barger and Basile, 2001; Qin et al.,
2006; Fogal et al., 2007; Savaskan et al., 2008; Sontheimer,
2008; Jackman et al., 2010b; Massie et al., 2011).
The chimaeric cultures were integral to our position that
glutamate effluxfrom astrocytesviasystemxc
2 contributedto
GD-inducedinjury.Yettheprecisemechanismbywhichsystem
xc
2 activity links to glutamate-mediated neuronal injury is yet
to be determined. It is possible that cellular changes in system
xc
2 expression or function occur under hypoglycaemic
conditions. With respect to the former, we did find that xCT
mRNA expression in mixed cultures was increased in a time-
dependent manner following GD. However, a statistically
significant increase in xCT mRNA (,4-fold) did not occur until
8 h after GD (Supplementary Figure S1 available at http://
www.asnneuro.org/an/004/an004e074add.htm). Given that
much, if not all, of the death has already occurred by
this time point, the relevance of this to the injury
mechanism is questioned. Further, it is important to point
out that it may not be necessary for enhanced release of
glutamate to occur because glutamate concentrations
needed to kill energy-deprived neurons are far less than
those required to kill healthy neurons (Novelli et al., 1988).
Additionally, it is possible that under conditions of
hypoglycaemia, glutamate uptake is impaired, allowing
system xc
2 derived glutamate to accumulate in the
extracellular space. However, there is a body of literature
demonstrating no change in glutamate uptake in primary
mouse cortical astrocytes following 2 h of GD (Bakken
et al., 1998) and only a 20% loss after 24 h (Swanson and
Benington, 1996). Finally, it is possible that following the
loss of system xc
2 function in the chimaeric cultures, its
substrate, L-cystine, is now fully available for neuronal
transport, perhaps yielding increased levels of neuronal GSH
that could enhance neuronal survival subsequent to
aglycaemic insult. However, this mechanism cannot explain
the protective effect demonstrated following pharmaco-
logical inhibition of system xc
2 as both neurons and
astrocyte transport are inhibited. Additionally, studies show
that neurons rely more heavily on cysteine rather than
cystine uptake for GSH biosynthetic needs (Kranich et al.,
1996) and that neuronal GSH content is intimately related
to astrocytic GSH levels secondary to extrusion of GSH
from astrocytes (Hirrlinger et al., 2002).
Regardless of the precise mechanism, our data demonstrate
that inhibition of system xc
2 through pharmacological means
is sufficient to dramatically reduce neuronal cell death
occurring secondary to GD and that genetic loss of astro-
cyte xCT recapitulates these findings. Conversely, the
enhancement of astrocyte system xc
2 activity that occurs
following IL-1b treatment exacerbates injury and facilitates
neuronal cell death. More broadly, these data highlight the
critical role of the astrocyte in non-cell autonomous
excitotoxic hypoglycaemic neuronal cell death and further
underscore their potential to serve as therapeutic targets for
reducing excitotoxic neuronal injury in vivo. Importantly, this
study adds to the burgeoning literature detailing the
contribution of astrocytes to acute neuronal injury (Fogal
et al., 2007; Jackman et al., 2010b) as well as in a variety of
neuropathological states (for review, see Barbeito et al., 2004;
Lobsiger and Cleveland, 2007). Acknowledging the limitations
of cell culture models, we suggest that more detailed studies
designed to assess the role of system xc
2 in hypoglycaemic
neurodegeneration in vivo are warranted.
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